Labcorp Holdings Inc. (LH) to Issue Quarterly Dividend of $0.72 on September 11th

Posted by Grant Hamersma on Aug 26th, 2026

Labcorp Holdings Inc. (NYSE:LH – Get Free Report) declared a quarterly dividend on Thursday, July 9th. Investors of record on Friday, August 28th will be paid a dividend of 0.72 per share by the medical research company on Friday, September 11th. This represents a c) annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Friday, August 28th.

Labcorp has a dividend payout ratio of 16.4% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Labcorp to earn $19.66 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 14.6%.

Labcorp Trading Down 0.5%

NYSE LH opened at $337.76 on Wednesday. Labcorp has a 1 year low of $244.52 and a 1 year high of $339.76. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.80 and a quick ratio of 1.53. The company has a market capitalization of $27.39 billion, a PE ratio of 27.94, a P/E/G ratio of 1.96 and a beta of 0.87. The company has a fifty day moving average of $295.47 and a 200 day moving average of $277.71.

Labcorp (NYSE:LH – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical research company reported $4.99 earnings per share for the quarter, topping the consensus estimate of $4.78 by $0.21. The company had revenue of $3.73 billion for the quarter, compared to the consensus estimate of $3.71 billion. Labcorp had a return on equity of 16.74% and a net margin of 6.99%.The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the firm earned $4.35 EPS. Labcorp has set its FY 2026 guidance at 18.100-18.550 EPS. Research analysts forecast that Labcorp will post 18.32 earnings per share for the current year.

Labcorp Company Profile

(Get Free Report)

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.